nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCC2—Lamivudine—hepatitis B	0.264	0.448	CbGbCtD
Telmisartan—ABCG2—Lamivudine—hepatitis B	0.239	0.405	CbGbCtD
Telmisartan—ABCB1—Lamivudine—hepatitis B	0.0862	0.146	CbGbCtD
Telmisartan—ABCC2—bile duct—hepatitis B	0.0245	0.365	CbGeAlD
Telmisartan—Sciatica—Telbivudine—hepatitis B	0.0117	0.0381	CcSEcCtD
Telmisartan—AGTR1—blood plasma—hepatitis B	0.00739	0.11	CbGeAlD
Telmisartan—Foetor hepaticus—Adefovir Dipivoxil—hepatitis B	0.007	0.0228	CcSEcCtD
Telmisartan—Myositis—Telbivudine—hepatitis B	0.00682	0.0222	CcSEcCtD
Telmisartan—PPARG—blood plasma—hepatitis B	0.00608	0.0907	CbGeAlD
Telmisartan—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.00583	0.019	CcSEcCtD
Telmisartan—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00486	0.0158	CcSEcCtD
Telmisartan—Influenza-like symptoms—Telbivudine—hepatitis B	0.00468	0.0153	CcSEcCtD
Telmisartan—CYP2C19—blood plasma—hepatitis B	0.00459	0.0685	CbGeAlD
Telmisartan—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.00397	0.0129	CcSEcCtD
Telmisartan—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.0039	0.0127	CcSEcCtD
Telmisartan—Rhabdomyolysis—Telbivudine—hepatitis B	0.00378	0.0123	CcSEcCtD
Telmisartan—SLCO1B3—liver—hepatitis B	0.00349	0.0521	CbGeAlD
Telmisartan—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.0033	0.0108	CcSEcCtD
Telmisartan—Influenza like illness—Telbivudine—hepatitis B	0.00325	0.0106	CcSEcCtD
Telmisartan—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00303	0.00988	CcSEcCtD
Telmisartan—Sepsis—Telbivudine—hepatitis B	0.0029	0.00946	CcSEcCtD
Telmisartan—Blood creatinine increased—Entecavir—hepatitis B	0.00277	0.00902	CcSEcCtD
Telmisartan—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00274	0.00893	CcSEcCtD
Telmisartan—AGTR1—blood—hepatitis B	0.00271	0.0404	CbGeAlD
Telmisartan—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0027	0.0088	CcSEcCtD
Telmisartan—Renal impairment—Telbivudine—hepatitis B	0.00255	0.00831	CcSEcCtD
Telmisartan—Pain in extremity—Telbivudine—hepatitis B	0.00243	0.00791	CcSEcCtD
Telmisartan—Migraine—Telbivudine—hepatitis B	0.00239	0.00779	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Entecavir—hepatitis B	0.00237	0.00774	CcSEcCtD
Telmisartan—Renal failure—Entecavir—hepatitis B	0.00224	0.0073	CcSEcCtD
Telmisartan—PPARG—blood—hepatitis B	0.00223	0.0332	CbGeAlD
Telmisartan—Cramp muscle—Telbivudine—hepatitis B	0.00219	0.00713	CcSEcCtD
Telmisartan—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00218	0.00712	CcSEcCtD
Telmisartan—Haematuria—Entecavir—hepatitis B	0.00217	0.00708	CcSEcCtD
Telmisartan—Hepatobiliary disease—Entecavir—hepatitis B	0.00215	0.00702	CcSEcCtD
Telmisartan—Gastritis—Telbivudine—hepatitis B	0.00215	0.007	CcSEcCtD
Telmisartan—Muscular weakness—Telbivudine—hepatitis B	0.00214	0.00698	CcSEcCtD
Telmisartan—Rhabdomyolysis—Lamivudine—hepatitis B	0.00213	0.00694	CcSEcCtD
Telmisartan—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00212	0.00691	CcSEcCtD
Telmisartan—AGTR1—liver—hepatitis B	0.00212	0.0316	CbGeAlD
Telmisartan—Abdominal distension—Telbivudine—hepatitis B	0.00211	0.00689	CcSEcCtD
Telmisartan—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.0021	0.00685	CcSEcCtD
Telmisartan—Bone disorder—Lamivudine—hepatitis B	0.00209	0.0068	CcSEcCtD
Telmisartan—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00209	0.00679	CcSEcCtD
Telmisartan—Oedema peripheral—Entecavir—hepatitis B	0.00201	0.00656	CcSEcCtD
Telmisartan—Abdominal discomfort—Telbivudine—hepatitis B	0.00201	0.00656	CcSEcCtD
Telmisartan—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00199	0.0065	CcSEcCtD
Telmisartan—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00198	0.00645	CcSEcCtD
Telmisartan—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00197	0.00642	CcSEcCtD
Telmisartan—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00196	0.00639	CcSEcCtD
Telmisartan—ABCC2—blood—hepatitis B	0.00196	0.0292	CbGeAlD
Telmisartan—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00196	0.00637	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00195	0.00636	CcSEcCtD
Telmisartan—ABCB1—blood plasma—hepatitis B	0.00192	0.0287	CbGeAlD
Telmisartan—Immune system disorder—Entecavir—hepatitis B	0.00185	0.00602	CcSEcCtD
Telmisartan—Renal failure—Telbivudine—hepatitis B	0.00184	0.00599	CcSEcCtD
Telmisartan—Neuropathy peripheral—Telbivudine—hepatitis B	0.00183	0.00598	CcSEcCtD
Telmisartan—Mental disorder—Entecavir—hepatitis B	0.00179	0.00584	CcSEcCtD
Telmisartan—Malnutrition—Entecavir—hepatitis B	0.00178	0.0058	CcSEcCtD
Telmisartan—Hepatobiliary disease—Telbivudine—hepatitis B	0.00177	0.00577	CcSEcCtD
Telmisartan—PPARG—liver—hepatitis B	0.00174	0.026	CbGeAlD
Telmisartan—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00174	0.00566	CcSEcCtD
Telmisartan—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00171	0.00558	CcSEcCtD
Telmisartan—CYP2C19—blood—hepatitis B	0.00168	0.0251	CbGeAlD
Telmisartan—Back pain—Adefovir Dipivoxil—hepatitis B	0.00168	0.00547	CcSEcCtD
Telmisartan—Hypoaesthesia—Telbivudine—hepatitis B	0.00167	0.00545	CcSEcCtD
Telmisartan—Pharyngitis—Telbivudine—hepatitis B	0.00167	0.00543	CcSEcCtD
Telmisartan—Connective tissue disorder—Telbivudine—hepatitis B	0.00165	0.00538	CcSEcCtD
Telmisartan—Sepsis—Lamivudine—hepatitis B	0.00164	0.00533	CcSEcCtD
Telmisartan—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00161	0.00523	CcSEcCtD
Telmisartan—Gastroenteritis—Lamivudine—hepatitis B	0.00154	0.00503	CcSEcCtD
Telmisartan—ABCC2—liver—hepatitis B	0.00153	0.0228	CbGeAlD
Telmisartan—Cough—Adefovir Dipivoxil—hepatitis B	0.00152	0.00494	CcSEcCtD
Telmisartan—Mediastinal disorder—Telbivudine—hepatitis B	0.00151	0.00493	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00151	0.0049	CcSEcCtD
Telmisartan—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00148	0.00482	CcSEcCtD
Telmisartan—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00148	0.00482	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00147	0.00479	CcSEcCtD
Telmisartan—Malnutrition—Telbivudine—hepatitis B	0.00146	0.00477	CcSEcCtD
Telmisartan—Anaphylactic shock—Entecavir—hepatitis B	0.00145	0.00473	CcSEcCtD
Telmisartan—Infection—Entecavir—hepatitis B	0.00144	0.0047	CcSEcCtD
Telmisartan—Renal impairment—Lamivudine—hepatitis B	0.00144	0.00469	CcSEcCtD
Telmisartan—Dysgeusia—Telbivudine—hepatitis B	0.00143	0.00467	CcSEcCtD
Telmisartan—ABCG2—blood—hepatitis B	0.00143	0.0213	CbGeAlD
Telmisartan—Nervous system disorder—Entecavir—hepatitis B	0.00142	0.00464	CcSEcCtD
Telmisartan—Back pain—Telbivudine—hepatitis B	0.00141	0.00461	CcSEcCtD
Telmisartan—Skin disorder—Entecavir—hepatitis B	0.00141	0.0046	CcSEcCtD
Telmisartan—Muscle spasms—Telbivudine—hepatitis B	0.00141	0.00458	CcSEcCtD
Telmisartan—Hypoglycaemia—Lamivudine—hepatitis B	0.0014	0.00457	CcSEcCtD
Telmisartan—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00139	0.00453	CcSEcCtD
Telmisartan—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00139	0.00452	CcSEcCtD
Telmisartan—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00138	0.00449	CcSEcCtD
Telmisartan—Ill-defined disorder—Telbivudine—hepatitis B	0.00136	0.00442	CcSEcCtD
Telmisartan—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00135	0.0044	CcSEcCtD
Telmisartan—Migraine—Lamivudine—hepatitis B	0.00135	0.00439	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—HLA-DPA1—hepatitis B	0.00132	0.0362	CbGpPWpGaD
Telmisartan—Malaise—Telbivudine—hepatitis B	0.00132	0.0043	CcSEcCtD
Telmisartan—CYP2C19—liver—hepatitis B	0.00131	0.0196	CbGeAlD
Telmisartan—Insomnia—Entecavir—hepatitis B	0.00131	0.00428	CcSEcCtD
Telmisartan—Somnolence—Entecavir—hepatitis B	0.00129	0.00421	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00129	0.00421	CcSEcCtD
Telmisartan—Dyspepsia—Entecavir—hepatitis B	0.00128	0.00417	CcSEcCtD
Telmisartan—Cough—Telbivudine—hepatitis B	0.00128	0.00416	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Entecavir—hepatitis B	0.00125	0.00409	CcSEcCtD
Telmisartan—Fatigue—Entecavir—hepatitis B	0.00125	0.00408	CcSEcCtD
Telmisartan—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00125	0.00407	CcSEcCtD
Telmisartan—Arthralgia—Telbivudine—hepatitis B	0.00124	0.00406	CcSEcCtD
Telmisartan—Chest pain—Telbivudine—hepatitis B	0.00124	0.00406	CcSEcCtD
Telmisartan—Myalgia—Telbivudine—hepatitis B	0.00124	0.00406	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00124	0.00403	CcSEcCtD
Telmisartan—Cramp muscle—Lamivudine—hepatitis B	0.00123	0.00402	CcSEcCtD
Telmisartan—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00123	0.00402	CcSEcCtD
Telmisartan—Discomfort—Telbivudine—hepatitis B	0.00123	0.00401	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00122	0.00399	CcSEcCtD
Telmisartan—SLCO1B3—Transport of organic anions—ALB—hepatitis B	0.00122	0.0334	CbGpPWpGaD
Telmisartan—Muscular weakness—Lamivudine—hepatitis B	0.00121	0.00393	CcSEcCtD
Telmisartan—Abdominal distension—Lamivudine—hepatitis B	0.00119	0.00388	CcSEcCtD
Telmisartan—Gastrointestinal pain—Entecavir—hepatitis B	0.00119	0.00387	CcSEcCtD
Telmisartan—Nervous system disorder—Telbivudine—hepatitis B	0.00117	0.00381	CcSEcCtD
Telmisartan—Thrombocytopenia—Telbivudine—hepatitis B	0.00117	0.00381	CcSEcCtD
Telmisartan—Skin disorder—Telbivudine—hepatitis B	0.00116	0.00378	CcSEcCtD
Telmisartan—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00116	0.00378	CcSEcCtD
Telmisartan—Sweating increased—Lamivudine—hepatitis B	0.00115	0.00375	CcSEcCtD
Telmisartan—Abdominal pain—Entecavir—hepatitis B	0.00115	0.00374	CcSEcCtD
Telmisartan—Body temperature increased—Entecavir—hepatitis B	0.00115	0.00374	CcSEcCtD
Telmisartan—Bronchitis—Lamivudine—hepatitis B	0.00114	0.00371	CcSEcCtD
Telmisartan—Abdominal discomfort—Lamivudine—hepatitis B	0.00113	0.0037	CcSEcCtD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00113	0.0308	CbGpPWpGaD
Telmisartan—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00112	0.00365	CcSEcCtD
Telmisartan—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00112	0.00365	CcSEcCtD
Telmisartan—ABCG2—liver—hepatitis B	0.00112	0.0167	CbGeAlD
Telmisartan—Dysuria—Lamivudine—hepatitis B	0.00111	0.0036	CcSEcCtD
Telmisartan—Pollakiuria—Lamivudine—hepatitis B	0.00109	0.00356	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00109	0.00354	CcSEcCtD
Telmisartan—Insomnia—Telbivudine—hepatitis B	0.00108	0.00352	CcSEcCtD
Telmisartan—Paraesthesia—Telbivudine—hepatitis B	0.00107	0.00349	CcSEcCtD
Telmisartan—Depression—Lamivudine—hepatitis B	0.00105	0.00343	CcSEcCtD
Telmisartan—Dyspepsia—Telbivudine—hepatitis B	0.00105	0.00342	CcSEcCtD
Telmisartan—Asthenia—Entecavir—hepatitis B	0.00104	0.0034	CcSEcCtD
Telmisartan—Renal failure—Lamivudine—hepatitis B	0.00104	0.00338	CcSEcCtD
Telmisartan—Neuropathy peripheral—Lamivudine—hepatitis B	0.00103	0.00337	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00103	0.00336	CcSEcCtD
Telmisartan—Fatigue—Telbivudine—hepatitis B	0.00103	0.00335	CcSEcCtD
Telmisartan—Pain—Telbivudine—hepatitis B	0.00102	0.00333	CcSEcCtD
Telmisartan—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00102	0.00331	CcSEcCtD
Telmisartan—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.00101	0.0277	CbGpPWpGaD
Telmisartan—Pruritus—Adefovir Dipivoxil—hepatitis B	0.001	0.00327	CcSEcCtD
Telmisartan—Hepatobiliary disease—Lamivudine—hepatitis B	0.000997	0.00325	CcSEcCtD
Telmisartan—Epistaxis—Lamivudine—hepatitis B	0.000995	0.00324	CcSEcCtD
Telmisartan—Diarrhoea—Entecavir—hepatitis B	0.000994	0.00324	CcSEcCtD
Telmisartan—Sinusitis—Lamivudine—hepatitis B	0.000989	0.00322	CcSEcCtD
Telmisartan—PPARG—Nuclear Receptors—HNF4A—hepatitis B	0.000989	0.027	CbGpPWpGaD
Telmisartan—Feeling abnormal—Telbivudine—hepatitis B	0.000983	0.0032	CcSEcCtD
Telmisartan—Gastrointestinal pain—Telbivudine—hepatitis B	0.000976	0.00318	CcSEcCtD
Telmisartan—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00097	0.00316	CcSEcCtD
Telmisartan—Dizziness—Entecavir—hepatitis B	0.000961	0.00313	CcSEcCtD
Telmisartan—Rhinitis—Lamivudine—hepatitis B	0.000949	0.00309	CcSEcCtD
Telmisartan—Body temperature increased—Telbivudine—hepatitis B	0.000943	0.00307	CcSEcCtD
Telmisartan—Abdominal pain—Telbivudine—hepatitis B	0.000943	0.00307	CcSEcCtD
Telmisartan—Hypoaesthesia—Lamivudine—hepatitis B	0.000942	0.00307	CcSEcCtD
Telmisartan—Pharyngitis—Lamivudine—hepatitis B	0.00094	0.00306	CcSEcCtD
Telmisartan—Connective tissue disorder—Lamivudine—hepatitis B	0.00093	0.00303	CcSEcCtD
Telmisartan—Vomiting—Entecavir—hepatitis B	0.000924	0.00301	CcSEcCtD
Telmisartan—Rash—Entecavir—hepatitis B	0.000916	0.00299	CcSEcCtD
Telmisartan—Dermatitis—Entecavir—hepatitis B	0.000915	0.00298	CcSEcCtD
Telmisartan—Headache—Entecavir—hepatitis B	0.00091	0.00297	CcSEcCtD
Telmisartan—SLCO1B3—Recycling of bile acids and salts—ALB—hepatitis B	0.000904	0.0247	CbGpPWpGaD
Telmisartan—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000901	0.00294	CcSEcCtD
Telmisartan—ABCC2—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000894	0.0245	CbGpPWpGaD
Telmisartan—Rash—Adefovir Dipivoxil—hepatitis B	0.000894	0.00291	CcSEcCtD
Telmisartan—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000893	0.00291	CcSEcCtD
Telmisartan—Headache—Adefovir Dipivoxil—hepatitis B	0.000888	0.00289	CcSEcCtD
Telmisartan—Nausea—Entecavir—hepatitis B	0.000863	0.00281	CcSEcCtD
Telmisartan—Asthenia—Telbivudine—hepatitis B	0.000856	0.00279	CcSEcCtD
Telmisartan—Immune system disorder—Lamivudine—hepatitis B	0.000855	0.00279	CcSEcCtD
Telmisartan—Mediastinal disorder—Lamivudine—hepatitis B	0.000853	0.00278	CcSEcCtD
Telmisartan—Chills—Lamivudine—hepatitis B	0.000849	0.00277	CcSEcCtD
Telmisartan—Pruritus—Telbivudine—hepatitis B	0.000844	0.00275	CcSEcCtD
Telmisartan—Nausea—Adefovir Dipivoxil—hepatitis B	0.000842	0.00274	CcSEcCtD
Telmisartan—Erythema—Lamivudine—hepatitis B	0.000824	0.00269	CcSEcCtD
Telmisartan—Malnutrition—Lamivudine—hepatitis B	0.000824	0.00269	CcSEcCtD
Telmisartan—Diarrhoea—Telbivudine—hepatitis B	0.000817	0.00266	CcSEcCtD
Telmisartan—Flatulence—Lamivudine—hepatitis B	0.000812	0.00265	CcSEcCtD
Telmisartan—Tension—Lamivudine—hepatitis B	0.000809	0.00264	CcSEcCtD
Telmisartan—Dysgeusia—Lamivudine—hepatitis B	0.000807	0.00263	CcSEcCtD
Telmisartan—Nervousness—Lamivudine—hepatitis B	0.0008	0.00261	CcSEcCtD
Telmisartan—Back pain—Lamivudine—hepatitis B	0.000797	0.0026	CcSEcCtD
Telmisartan—Muscle spasms—Lamivudine—hepatitis B	0.000792	0.00258	CcSEcCtD
Telmisartan—Dizziness—Telbivudine—hepatitis B	0.000789	0.00257	CcSEcCtD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.000781	0.0214	CbGpPWpGaD
Telmisartan—Ill-defined disorder—Lamivudine—hepatitis B	0.000765	0.00249	CcSEcCtD
Telmisartan—Anaemia—Lamivudine—hepatitis B	0.000762	0.00248	CcSEcCtD
Telmisartan—Vomiting—Telbivudine—hepatitis B	0.000759	0.00247	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.000759	0.0207	CbGpPWpGaD
Telmisartan—Angioedema—Lamivudine—hepatitis B	0.000753	0.00245	CcSEcCtD
Telmisartan—Rash—Telbivudine—hepatitis B	0.000753	0.00245	CcSEcCtD
Telmisartan—Dermatitis—Telbivudine—hepatitis B	0.000752	0.00245	CcSEcCtD
Telmisartan—Headache—Telbivudine—hepatitis B	0.000748	0.00244	CcSEcCtD
Telmisartan—Malaise—Lamivudine—hepatitis B	0.000743	0.00242	CcSEcCtD
Telmisartan—Vertigo—Lamivudine—hepatitis B	0.00074	0.00241	CcSEcCtD
Telmisartan—Syncope—Lamivudine—hepatitis B	0.000739	0.00241	CcSEcCtD
Telmisartan—Loss of consciousness—Lamivudine—hepatitis B	0.000724	0.00236	CcSEcCtD
Telmisartan—Cough—Lamivudine—hepatitis B	0.000719	0.00234	CcSEcCtD
Telmisartan—Nausea—Telbivudine—hepatitis B	0.000709	0.00231	CcSEcCtD
Telmisartan—ABCB1—blood—hepatitis B	0.000703	0.0105	CbGeAlD
Telmisartan—Arthralgia—Lamivudine—hepatitis B	0.000702	0.00229	CcSEcCtD
Telmisartan—Myalgia—Lamivudine—hepatitis B	0.000702	0.00229	CcSEcCtD
Telmisartan—Chest pain—Lamivudine—hepatitis B	0.000702	0.00229	CcSEcCtD
Telmisartan—Anxiety—Lamivudine—hepatitis B	0.000699	0.00228	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000697	0.00227	CcSEcCtD
Telmisartan—Discomfort—Lamivudine—hepatitis B	0.000693	0.00226	CcSEcCtD
Telmisartan—Dry mouth—Lamivudine—hepatitis B	0.000686	0.00224	CcSEcCtD
Telmisartan—Anaphylactic shock—Lamivudine—hepatitis B	0.000673	0.00219	CcSEcCtD
Telmisartan—Oedema—Lamivudine—hepatitis B	0.000673	0.00219	CcSEcCtD
Telmisartan—Infection—Lamivudine—hepatitis B	0.000668	0.00218	CcSEcCtD
Telmisartan—Shock—Lamivudine—hepatitis B	0.000662	0.00216	CcSEcCtD
Telmisartan—Nervous system disorder—Lamivudine—hepatitis B	0.00066	0.00215	CcSEcCtD
Telmisartan—Thrombocytopenia—Lamivudine—hepatitis B	0.000659	0.00215	CcSEcCtD
Telmisartan—Skin disorder—Lamivudine—hepatitis B	0.000653	0.00213	CcSEcCtD
Telmisartan—Hyperhidrosis—Lamivudine—hepatitis B	0.00065	0.00212	CcSEcCtD
Telmisartan—Anorexia—Lamivudine—hepatitis B	0.000641	0.00209	CcSEcCtD
Telmisartan—Hypotension—Lamivudine—hepatitis B	0.000628	0.00205	CcSEcCtD
Telmisartan—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.000627	0.0172	CbGpPWpGaD
Telmisartan—AGTR1—ACE Inhibitor Pathway—TGFB1—hepatitis B	0.000624	0.0171	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000613	0.002	CcSEcCtD
Telmisartan—Insomnia—Lamivudine—hepatitis B	0.000608	0.00198	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000608	0.0166	CbGpPWpGaD
Telmisartan—Paraesthesia—Lamivudine—hepatitis B	0.000604	0.00197	CcSEcCtD
Telmisartan—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000603	0.0165	CbGpPWpGaD
Telmisartan—Dyspnoea—Lamivudine—hepatitis B	0.0006	0.00195	CcSEcCtD
Telmisartan—Somnolence—Lamivudine—hepatitis B	0.000598	0.00195	CcSEcCtD
Telmisartan—Dyspepsia—Lamivudine—hepatitis B	0.000592	0.00193	CcSEcCtD
Telmisartan—Decreased appetite—Lamivudine—hepatitis B	0.000585	0.00191	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000581	0.00189	CcSEcCtD
Telmisartan—Fatigue—Lamivudine—hepatitis B	0.00058	0.00189	CcSEcCtD
Telmisartan—Pain—Lamivudine—hepatitis B	0.000575	0.00187	CcSEcCtD
Telmisartan—Constipation—Lamivudine—hepatitis B	0.000575	0.00187	CcSEcCtD
Telmisartan—Feeling abnormal—Lamivudine—hepatitis B	0.000554	0.00181	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—MIF—hepatitis B	0.000552	0.0151	CbGpPWpGaD
Telmisartan—ABCB1—liver—hepatitis B	0.00055	0.00821	CbGeAlD
Telmisartan—Gastrointestinal pain—Lamivudine—hepatitis B	0.00055	0.00179	CcSEcCtD
Telmisartan—Urticaria—Lamivudine—hepatitis B	0.000534	0.00174	CcSEcCtD
Telmisartan—Abdominal pain—Lamivudine—hepatitis B	0.000532	0.00173	CcSEcCtD
Telmisartan—Body temperature increased—Lamivudine—hepatitis B	0.000532	0.00173	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—F2—hepatitis B	0.000501	0.0137	CbGpPWpGaD
Telmisartan—Hypersensitivity—Lamivudine—hepatitis B	0.000496	0.00161	CcSEcCtD
Telmisartan—Asthenia—Lamivudine—hepatitis B	0.000483	0.00157	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—hepatitis B	0.000481	0.0132	CbGpPWpGaD
Telmisartan—Pruritus—Lamivudine—hepatitis B	0.000476	0.00155	CcSEcCtD
Telmisartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—hepatitis B	0.000472	0.0129	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000463	0.0127	CbGpPWpGaD
Telmisartan—Diarrhoea—Lamivudine—hepatitis B	0.00046	0.0015	CcSEcCtD
Telmisartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—hepatitis B	0.000452	0.0124	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—CD40LG—hepatitis B	0.000448	0.0123	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL10—hepatitis B	0.000448	0.0123	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—hepatitis B	0.000447	0.0122	CbGpPWpGaD
Telmisartan—Dizziness—Lamivudine—hepatitis B	0.000445	0.00145	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—GGT2—hepatitis B	0.000438	0.012	CbGpPWpGaD
Telmisartan—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000431	0.0118	CbGpPWpGaD
Telmisartan—Vomiting—Lamivudine—hepatitis B	0.000428	0.00139	CcSEcCtD
Telmisartan—AGTR1—Peptide GPCRs—CCR5—hepatitis B	0.000427	0.0117	CbGpPWpGaD
Telmisartan—Rash—Lamivudine—hepatitis B	0.000424	0.00138	CcSEcCtD
Telmisartan—Dermatitis—Lamivudine—hepatitis B	0.000424	0.00138	CcSEcCtD
Telmisartan—Headache—Lamivudine—hepatitis B	0.000421	0.00137	CcSEcCtD
Telmisartan—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00042	0.0115	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—FASLG—hepatitis B	0.000416	0.0114	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—FAS—hepatitis B	0.000402	0.011	CbGpPWpGaD
Telmisartan—Nausea—Lamivudine—hepatitis B	0.0004	0.0013	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—HLA-A—hepatitis B	0.000395	0.0108	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.000388	0.0106	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000361	0.00986	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—TNF—hepatitis B	0.000353	0.00965	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 trafficking events—CTNNB1—hepatitis B	0.000342	0.00936	CbGpPWpGaD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hepatitis B	0.000331	0.00905	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—hepatitis B	0.000318	0.0087	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—hepatitis B	0.000316	0.00864	CbGpPWpGaD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—hepatitis B	0.000309	0.00845	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—IL6—hepatitis B	0.000285	0.00779	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—hepatitis B	0.000283	0.00773	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—CYP2A6—hepatitis B	0.000265	0.00726	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IFNG—hepatitis B	0.000263	0.0072	CbGpPWpGaD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00026	0.00712	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCL10—hepatitis B	0.000259	0.00708	CbGpPWpGaD
Telmisartan—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000257	0.00703	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—hepatitis B	0.000251	0.00687	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000251	0.00685	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—hepatitis B	0.000246	0.00672	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000235	0.00644	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—hepatitis B	0.000235	0.00643	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL2—hepatitis B	0.000234	0.0064	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDKN2A—hepatitis B	0.000232	0.00635	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000215	0.00589	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000215	0.00589	CbGpPWpGaD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000211	0.00578	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—GGT1—hepatitis B	0.000207	0.00567	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCR5—hepatitis B	0.000201	0.00549	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—FAS—hepatitis B	0.000201	0.00549	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—NR0B2—hepatitis B	0.000195	0.00532	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.00019	0.00521	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDKN1A—hepatitis B	0.00019	0.00519	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000185	0.00506	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000184	0.00502	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—hepatitis B	0.000183	0.00501	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TGFB1—hepatitis B	0.000183	0.00499	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—NFKB1—hepatitis B	0.00018	0.00492	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000178	0.00488	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—F2—hepatitis B	0.000174	0.00477	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000174	0.00475	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—F2—hepatitis B	0.000172	0.00471	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TNF—hepatitis B	0.00017	0.00466	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—NFKB1—hepatitis B	0.000167	0.00456	CbGpPWpGaD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—hepatitis B	0.000164	0.00449	CbGpPWpGaD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000157	0.0043	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000156	0.00427	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000147	0.00402	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—FAS—hepatitis B	0.000142	0.00387	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—hepatitis B	0.00014	0.00382	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—hepatitis B	0.000139	0.00379	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—HNF4A—hepatitis B	0.000135	0.00369	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000135	0.00368	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCL10—hepatitis B	0.000132	0.00362	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000131	0.0036	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000131	0.0036	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—hepatitis B	0.00013	0.00354	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HNF4A—hepatitis B	0.000127	0.00347	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000122	0.00334	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—NOS2—hepatitis B	0.000121	0.00331	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000118	0.00322	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000116	0.00318	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000116	0.00317	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000116	0.00316	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—CTNNB1—hepatitis B	0.000113	0.00309	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000112	0.00307	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—CDKN1A—hepatitis B	0.00011	0.00302	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000107	0.00293	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000106	0.0029	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCR5—hepatitis B	0.000103	0.0028	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SAG—hepatitis B	0.000102	0.00278	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RIT2—hepatitis B	0.000102	0.00278	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.76e-05	0.00267	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—hepatitis B	9.71e-05	0.00266	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKR1B1—hepatitis B	9.58e-05	0.00262	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NR0B2—hepatitis B	9.37e-05	0.00256	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GGT2—hepatitis B	9.19e-05	0.00251	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TGFB1—hepatitis B	9.13e-05	0.0025	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—F2—hepatitis B	8.8e-05	0.00241	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—GGT1—hepatitis B	8.76e-05	0.0024	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TNF—hepatitis B	8.52e-05	0.00233	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.33e-05	0.00228	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKR1B1—hepatitis B	8.18e-05	0.00224	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GGT2—hepatitis B	7.84e-05	0.00214	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—PTEN—hepatitis B	7.77e-05	0.00212	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IFNG—hepatitis B	7.73e-05	0.00211	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL10—hepatitis B	7.47e-05	0.00204	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	7.42e-05	0.00203	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TGFB1—hepatitis B	6.97e-05	0.00191	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—IL6—hepatitis B	6.88e-05	0.00188	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL2—hepatitis B	6.87e-05	0.00188	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL10—hepatitis B	6.79e-05	0.00186	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HNF4A—hepatitis B	6.5e-05	0.00178	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	6.18e-05	0.00169	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	6.03e-05	0.00165	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKR1B1—hepatitis B	5.96e-05	0.00163	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	5.82e-05	0.00159	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCR5—hepatitis B	5.79e-05	0.00158	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GGT2—hepatitis B	5.72e-05	0.00156	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP2A6—hepatitis B	5.57e-05	0.00152	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TGFB1—hepatitis B	5.36e-05	0.00147	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—hepatitis B	5.3e-05	0.00145	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCR5—hepatitis B	5.26e-05	0.00144	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.19e-05	0.00142	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GOT2—hepatitis B	5.03e-05	0.00138	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—hepatitis B	5e-05	0.00137	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—F2—hepatitis B	4.97e-05	0.00136	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ALB—hepatitis B	4.94e-05	0.00135	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—hepatitis B	4.85e-05	0.00133	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP2A6—hepatitis B	4.75e-05	0.0013	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—F2—hepatitis B	4.51e-05	0.00123	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.43e-05	0.00121	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GGT1—hepatitis B	4.35e-05	0.00119	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GOT1—hepatitis B	4.35e-05	0.00119	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GOT2—hepatitis B	4.3e-05	0.00117	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL10—hepatitis B	4.01e-05	0.0011	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.96e-05	0.00108	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CTNNB1—hepatitis B	3.88e-05	0.00106	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NFKB1—hepatitis B	3.77e-05	0.00103	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GGT1—hepatitis B	3.71e-05	0.00101	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GOT1—hepatitis B	3.71e-05	0.00101	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—hepatitis B	3.53e-05	0.000966	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP2A6—hepatitis B	3.46e-05	0.000947	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.38e-05	0.000924	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	3.36e-05	0.00092	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—hepatitis B	3.35e-05	0.000916	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKR1B1—hepatitis B	3.3e-05	0.000903	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	3.27e-05	0.000895	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKR1B1—hepatitis B	3.22e-05	0.000882	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	3.2e-05	0.000874	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	3.19e-05	0.000872	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	3.17e-05	0.000868	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GGT2—hepatitis B	3.17e-05	0.000866	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—hepatitis B	3.14e-05	0.000858	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GOT2—hepatitis B	3.13e-05	0.000857	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR5—hepatitis B	3.11e-05	0.00085	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GGT2—hepatitis B	3.09e-05	0.000845	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	3.07e-05	0.00084	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—hepatitis B	3.04e-05	0.000832	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—hepatitis B	2.93e-05	0.000801	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GGT1—hepatitis B	2.7e-05	0.000739	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GOT1—hepatitis B	2.7e-05	0.000739	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—F2—hepatitis B	2.67e-05	0.000729	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	2.64e-05	0.000723	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	2.47e-05	0.000675	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—hepatitis B	2.36e-05	0.000646	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—hepatitis B	2.31e-05	0.000632	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.18e-05	0.000595	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—hepatitis B	1.97e-05	0.000539	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2A6—hepatitis B	1.92e-05	0.000525	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2A6—hepatitis B	1.87e-05	0.000512	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—hepatitis B	1.8e-05	0.000491	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.79e-05	0.000489	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—hepatitis B	1.79e-05	0.000489	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—hepatitis B	1.76e-05	0.000482	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GOT2—hepatitis B	1.73e-05	0.000474	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—hepatitis B	1.73e-05	0.000474	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—hepatitis B	1.69e-05	0.000463	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GOT2—hepatitis B	1.69e-05	0.000463	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—hepatitis B	1.69e-05	0.000462	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NFKB1—hepatitis B	1.68e-05	0.00046	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.66e-05	0.000454	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—hepatitis B	1.5e-05	0.000412	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GOT1—hepatitis B	1.5e-05	0.00041	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GGT1—hepatitis B	1.5e-05	0.00041	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GGT1—hepatitis B	1.46e-05	0.0004	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GOT1—hepatitis B	1.46e-05	0.0004	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—hepatitis B	1.44e-05	0.000393	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—hepatitis B	1.4e-05	0.000383	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.36e-05	0.000373	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—hepatitis B	1.15e-05	0.000315	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—hepatitis B	1.1e-05	0.0003	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—hepatitis B	1.06e-05	0.000289	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—hepatitis B	7.97e-06	0.000218	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—hepatitis B	7.77e-06	0.000213	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—hepatitis B	6.08e-06	0.000166	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—hepatitis B	5.93e-06	0.000162	CbGpPWpGaD
